CSF3R and acute lymphoblastic leukemia: Second, the mechanism by which the CAG regimen affects T‐ALL cells remains unclear, although a previous study found that T‐ALL cells highly express G‐CSF receptors, and G‐CSF has a synergetic effect in eliminating T‐ALL cells when administered simultaneously with araC and aclarubicin.34